Clinical Trials Browser

Phase 4 × Breast Neoplasms × LY 353381 × Clear all

NCT00190697 2007-05-25

A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment

Phase 4 Completed

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms